Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats

Background Clinical trials have indicated that finerenone, a nonsteroidal mineralocorticoid receptor antagonist, elicits considerable cardiovascular protective benefits; however, its precise mechanism of action remains to be fully elucidated. Methods Here, we examined the impact of finerenone on myo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Asadur Rahman, Tatsuya Sawano, Kento Kitada, Nourin Jahan, Yoshihide Fujisawa, Keiko Yamakawa, Md Moshiur Rahman, Juanjuan Ye, Md Enayet Kabir, Kyuichi Kadota, Takeshi Imamura, Hiroyuki Ohsaki, Daisuke Yamazaki, Takashi Morikawa, Yoshio Konishi, Akira Nishiyama
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-03-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	aldosterone cardiovascular diseases finerenone mineralocorticoid receptor antagonist salt
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.125.044798
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!